128 related articles for article (PubMed ID: 15899059)
1. Gastrin-releasing peptide, substance P and cytokines in rheumatoid arthritis.
Green PG
Arthritis Res Ther; 2005; 7(3):111-3. PubMed ID: 15899059
[TBL] [Abstract][Full Text] [Related]
2. Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis.
Grimsholm O; Rantapää-Dahlqvist S; Forsgren S
Arthritis Res Ther; 2005; 7(3):R416-26. PubMed ID: 15899028
[TBL] [Abstract][Full Text] [Related]
3. Increased content of bombesin/GRP in human synovial fluid in early arthritis: different pattern compared with substance P.
Westermark T; Rantapää-Dahlqvist S; Wållberg-Jonsson S; Kjörell U; Forsgren S
Clin Exp Rheumatol; 2001; 19(6):715-20. PubMed ID: 11791645
[TBL] [Abstract][Full Text] [Related]
4. Observations favouring the occurrence of local production and marked effects of bombesin/gastrin-releasing peptide in the synovial tissue of the human knee joint--comparisons with substance P and the NK-1 receptor.
Grimsholm O; Rantapää-Dahlqvist S; Dalén T; Forsgren S
Neuropeptides; 2008 Apr; 42(2):133-45. PubMed ID: 18289674
[TBL] [Abstract][Full Text] [Related]
5. Are neuropeptides important in arthritis? Studies on the importance of bombesin/GRP and substance P in a murine arthritis model.
Grimsholm O; Guo Y; Ny T; Rantapää-Dahlqvist S; Forsgren S
Ann N Y Acad Sci; 2007 Sep; 1110():525-38. PubMed ID: 17911468
[TBL] [Abstract][Full Text] [Related]
6. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptides in the arthritic TMJ and symptoms and signs from the stomatognathic system with special consideration to rheumatoid arthritis.
Appelgren A; Appelgren B; Kopp S; Lundeberg T; Theodorsson E
J Orofac Pain; 1995; 9(3):215-25. PubMed ID: 8995921
[TBL] [Abstract][Full Text] [Related]
8. Reduction in serum levels of substance P in patients with rheumatoid arthritis by etanercept, a tumor necrosis factor inhibitor.
Origuchi T; Iwamoto N; Kawashiri SY; Fujikawa K; Aramaki T; Tamai M; Arima K; Nakamura H; Yamasaki S; Ida H; Kawakami A; Ueki Y; Matsuoka N; Nakashima M; Mizokami A; Kawabe Y; Mine M; Fukuda T; Eguchi K
Mod Rheumatol; 2011 Jun; 21(3):244-50. PubMed ID: 21188454
[TBL] [Abstract][Full Text] [Related]
9. [Cytokines in rheumatoid arthritis. I. Proinflammatory cytokines].
Klimiuk PA; Sierakowski S
Pol Merkur Lekarski; 2001 Dec; 11(66):510-3. PubMed ID: 11899850
[TBL] [Abstract][Full Text] [Related]
10. Substance P ameliorates collagen II-induced arthritis in mice via suppression of the inflammatory response.
Hong HS; Son Y
Biochem Biophys Res Commun; 2014 Oct; 453(1):179-84. PubMed ID: 25264193
[TBL] [Abstract][Full Text] [Related]
11. Role of cytokines in rheumatoid arthritis.
Feldmann M; Brennan FM; Maini RN
Annu Rev Immunol; 1996; 14():397-440. PubMed ID: 8717520
[TBL] [Abstract][Full Text] [Related]
12. Update on cytokines in rheumatoid arthritis.
Brennan F; Beech J
Curr Opin Rheumatol; 2007 May; 19(3):296-301. PubMed ID: 17414959
[TBL] [Abstract][Full Text] [Related]
13. [Cytokines in rheumatoid arthritis. II. Anti-inflammatory cytokines].
Klimiuk PA; Sierakowski S
Pol Merkur Lekarski; 2001 Dec; 11(66):514-6. PubMed ID: 11899851
[TBL] [Abstract][Full Text] [Related]
14. [Interleukin-1 in the pathogenesis of chronic polyarthritis].
Warnatz H; Ruschen S; Lemm G
Med Klin (Munich); 1990 May; 85(5):302-7. PubMed ID: 2113162
[TBL] [Abstract][Full Text] [Related]
15. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
Mathsson L; Lampa J; Mullazehi M; Rönnelid J
Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
[TBL] [Abstract][Full Text] [Related]
16. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
[TBL] [Abstract][Full Text] [Related]
17. Reduction of temporomandibular joint pain after treatment with a combination of methotrexate and infliximab is associated with changes in synovial fluid and plasma cytokines in rheumatoid arthritis.
Kopp S; Alstergren P; Ernestam S; Nordahl S; Morin P; Bratt J
Cells Tissues Organs; 2005; 180(1):22-30. PubMed ID: 16088130
[TBL] [Abstract][Full Text] [Related]
18. Synovial fluid from rheumatoid arthritis patients contains sufficient levels of IL-1 beta and IL-6 to promote production of serum amyloid A by Hep3B cells.
McNiff PA; Stewart C; Sullivan J; Showell HJ; Gabel CA
Cytokine; 1995 Feb; 7(2):209-19. PubMed ID: 7780041
[TBL] [Abstract][Full Text] [Related]
19. Evidence for neural regulation of inflammatory synovial cell functions by secreting calcitonin gene-related peptide and vasoactive intestinal peptide in patients with rheumatoid arthritis.
Takeba Y; Suzuki N; Kaneko A; Asai T; Sakane T
Arthritis Rheum; 1999 Nov; 42(11):2418-29. PubMed ID: 10555038
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 subfamily cytokines and rheumatoid arthritis: role of antagonists.
Jazayeri JA; Carroll GJ; Vernallis AB
Int Immunopharmacol; 2010 Jan; 10(1):1-8. PubMed ID: 19804846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
